Denver, Colorado – Wall Street is navigating a crosscurrent of aggressive AI pivots and long-dated autonomy bets, as companies across sectors reposition for what looks like a more competitive, and more technologically driven, cycle ahead.
Uber and Rivian Make a $1.25B Bet
In one of the most consequential announcements, UBER (NYSE:UBER) and RIVN (NASDAQ:RIVN) unveiled a massive autonomous vehicle partnership.
Key elements:
Up to $1.25 billion investment from Uber into Rivian through 2031
Initial deployment of 10,000 autonomous R2 robotaxis
Potential expansion to 50,000 vehicles
Rollout starting in San Francisco and Miami (2028), scaling to 25 cities
Uber CEO Dara Khosrowshahi emphasized confidence in Rivian’s vertically integrated approach, while Rivian CEO RJ Scaringe highlighted the company’s data flywheel and in-house AI compute platform as central to achieving Level 4 autonomy.
This deal underscores a broader shift in the autonomous race from just software to integrated ecosystems spanning vehicles, data, and fleet operations.
For investors, the timeline is long, but the strategic positioning is immediate.
TGNT Targets Biologics + Medical Tourism
TGNT (OTCID:TGNT) is attempting a high-concept pivot into biologics and medical tourism infrastructure.
Two February LOIs outline the strategy:
A joint venture with GloMed targeting APAC biologics distribution
An acqui-hire of Aetherium Medical assets focused on AI-enabled drug logistics and commercialization
The pitch is ambitious: combining AI-driven biologics development with cross-border treatment pathways that bypass slower regulatory channels. Management is effectively betting on the convergence of:
a projected $650B biologics market by 2030
and a rapidly expanding medical tourism sector
Execution is the key, as the structure (minimal upfront cash, milestone-based equity) suggests a capital-light attempt to enter two fast-growing verticals simultaneously.
CHNR Reinvents Itself
CHNR (NASDAQ:CHNR) is signaling a dramatic identity shift, announcing a non-binding deal to acquire a majority stake in HooRii Technology, an AI + IoT company focused on “physical AI.”
The proposed $37–$40 million transaction would:
Integrate AI into CHNR’s mining operations
Expand the company into AI-enabled industrial applications
Management framed the move as both defensive and opportunistic, modernizing legacy operations while building exposure to a fast-scaling AI ecosystem.
It’s another example of a growing trend:
Traditional industries are not just adopting AI, they’re restructuring around it.
Biotech Financing Window Reopens
Meanwhile, SER (NYSE:SER) secured up to $30 million in private placement financing, with the first $15 million tranche expected to close immediately.
Notably:
Shares priced at $2.25, a 68% premium to market
Warrants priced at $5.00 (273% premium)
Proceeds fund a registrational study for SER-252 targeting advanced Parkinson’s disease
The structure, premium pricing plus milestone-based capital, signals renewed investor willingness to fund clinical-stage biotech, provided there’s:
a clear regulatory pathway (505(b)(2))
and near-term catalysts
Mortgage REIT Drama: TWO Caught Between Bidders
TWO (NYSE:TWO) is suddenly at the center of a potential bidding contest; after confirming it received an unsolicited $10.70 per share all-cash offer, a move that could disrupt its existing merger agreement with UWMC (NYSE:UWMC).
The company’s ad hoc board committee has already determined the proposal “could reasonably be expected” to become a superior offer, a key legal threshold that allows engagement under the current deal terms. Importantly, the unsolicited bid also covers the $25.4 million termination fee tied to the UWMC transaction.
Still, the existing deal isn’t dead. TWO continues to recommend the UWMC merger, for now, with a shareholder vote scheduled for March 24, 2026, setting up a near-term catalyst where either:
a revised UWMC bid emerges, or
a new buyer formalizes a competing deal
This puts TWO squarely in event-driven territory, where arbitrage spreads and headline risk will likely dominate trading.
About 24/7 Market News
In today's fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you're an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247marketnews.com to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies for providing ongoing TGNT market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://go.247marketnews.com/tgnt-disclosure/ for further TGNT and 247marketnews.com disclosure information.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.